These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16249391)

  • 1. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.
    Kavanagh DG; Kaufmann DE; Sunderji S; Frahm N; Le Gall S; Boczkowski D; Rosenberg ES; Stone DR; Johnston MN; Wagner BS; Zaman MT; Brander C; Gilboa E; Walker BD; Bhardwaj N
    Blood; 2006 Mar; 107(5):1963-9. PubMed ID: 16249391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
    Melhem NM; Liu XD; Boczkowski D; Gilboa E; Barratt-Boyes SM
    Eur J Immunol; 2007 Aug; 37(8):2164-73. PubMed ID: 17615585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients.
    Silvestris F; Camarda G; Del Prete A; Tucci M; Dammacco F
    Eur J Clin Invest; 1999 Nov; 29(11):980-91. PubMed ID: 10583444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.
    Gandhi RT; Kwon DS; Macklin EA; Shopis JR; McLean AP; McBrine N; Flynn T; Peter L; Sbrolla A; Kaufmann DE; Porichis F; Walker BD; Bhardwaj N; Barouch DH; Kavanagh DG
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):246-53. PubMed ID: 26379068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.
    Van Nuffel AM; Benteyn D; Wilgenhof S; Pierret L; Corthals J; Heirman C; van der Bruggen P; Coulie PG; Neyns B; Thielemans K; Bonehill A
    Mol Ther; 2012 May; 20(5):1063-74. PubMed ID: 22371843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of HIV-1-infected fibrocytes lacking Nef-mediated HLA-B downregulation by HIV-1-specific T cells.
    Kuse N; Noyori O; Takahashi N; Zhang Y; Suzu S; Takiguchi M
    J Virol; 2024 Jul; 98(7):e0079124. PubMed ID: 38940584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
    Yang H; Dong T; Turnbull E; Ranasinghe S; Ondondo B; Goonetilleke N; Winstone N; di Gleria K; Bowness P; Conlon C; Borrow P; Hanke T; McMichael A; Dorrell L
    J Immunol; 2007 Jul; 179(1):597-606. PubMed ID: 17579081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
    J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects.
    Chassin D; Andrieu M; Cohen W; Culmann-Penciolelli B; Ostankovitch M; Hanau D; Guillet JG
    Eur J Immunol; 1999 Jan; 29(1):196-202. PubMed ID: 9933101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.
    Allard SD; Pletinckx K; Breckpot K; Heirman C; Bonehill A; Michiels A; van Baalen CA; Gruters RA; Osterhaus AD; Lacor P; Thielemans K; Aerts JL
    Vaccine; 2008 Jul; 26(29-30):3735-41. PubMed ID: 18539368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
    de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
    AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells.
    Flamar AL; Xue Y; Zurawski SM; Montes M; King B; Sloan L; Oh S; Banchereau J; Levy Y; Zurawski G
    AIDS; 2013 Aug; 27(13):2041-51. PubMed ID: 23615121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.